The US Food and Drug Administration has issued a new rule to ensure its drug registry is more accurate and up-to-date. The Electronic Drug Registration and Listing System would make the complete list of drugs marketed in the USA accessible electronically. At present, part of the list exists in paper format only.
The FDA estimates that there are more than 120,000 products on the list, which is used by other government agencies, health care providers and health care payers. Mike Leavitt, the Department of Health and Human Services Secretary, said: "this will help us to maintain more accurate information and make it easier for us to respond to drug emergencies such as recalls and drug shortages."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze